Goldman Sachs say escalating US-China tariff tensions a downside risk to economic growthApril 8, 2025
Market Trends Entrada Therapeutics gets approval to start trial of its DMD treatment in the UK (TRDA:NASDAQ)By admin8996erT0allMarch 24, 2025 Dr_Microbe/iStock via Getty ImagesEntrada Therapeutics (NASDAQ:TRDA) said on Monday that it has received approval from the U.K.’s Medicines and Healthcare…
